- Emphasizes practical clinical presentations and management of commonly seen problems, making this text an excellent resource for daily decision making.
- Provides in-depth explanations of major topics supplemented with up-to-date references.
- Features a new chapter on Immunotherapy in Gynecologic Malignancies, updated information on invasive cervical cancer, and significantly revised content on vulvar cancer, with new guidance on micro-staging for sentinels.
- Covers key topics such as precision medicine and new biomarker-driven targeted therapies, cancer staging, targeted therapy, and immunotherapy.
- Includes quick-reference features such as key point boxes with bulleted lists, highlighted key text, enhanced chapter outlines, clinical algorithms that review recommended treatment and management options, and additional references online.
- Contains useful appendices covering staging, screening, nutritional therapy, toxicity criteria, blood component therapy, and radiation therapy.
- An ideal comprehensive resource for clinical practice, personal study, and exam review.
- Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.
DiSaia and Creasman Clinical Gynecologic Oncology, 10th Edition
For more than 40 years, DiSaia and Creasman Clinical Gynecologic Oncology has been the leading reference for diagnosis and treatment of gynecologic cancers, providing physicians and trainees alike with expert guidance on clinical presentations and management. The fully revised 10th Edition remains the most readable, most comprehensive text in the field. Under outstanding editorial leadership from Dr. William Creasman and featuring a “who’s who list of expert contributing authors, this authoritative reference is a must-have resource for improving outcomes and providing effective patient care.
Edited by William T. Creasman, MD, Sims-Hester Professor and Chairman, Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, South Carolina; Robert S Mannel, MD, Professor, Division of Gynecologic Oncology, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma; David G Mutch, MD, Ira C. and Judith Call Professor of Obstetrics and Gynecology, Department of Obstetrics and Gynecology, Vice Chair of Gynecology, Washington University School of Medicine, St. Louis, Missouri and Krishnansu Tewari, MD, FACOG, FACS, FRSM, Professor & Division Director, Division of Gynecologic Oncology, University of California, Irvine, Irvine, California